Statistics
Total Visits
| Views | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 608 |
Total Visits Per Month
| February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 32 | 28 | 41 | 59 | 55 | 43 | 24 |
File Visits
| Views | |
|---|---|
| Registro IRESP.PROB 2.pdf | 219 |
Top country views
| Views | |
|---|---|
| United States | 172 |
| Germany | 80 |
| Singapore | 71 |
| Hong Kong | 45 |
| Brazil | 38 |
| Ireland | 22 |
| United Kingdom | 21 |
| Vietnam | 20 |
| Spain | 15 |
| Mexico | 14 |
Top cities views
| Views | |
|---|---|
| Frankfurt am Main | 76 |
| Ashburn | 63 |
| Hong Kong | 43 |
| Council Bluffs | 24 |
| Dublin | 22 |
| San Jose | 14 |
| Singapore | 13 |
| Hanoi | 9 |
| Mexico City | 8 |
| Santafé | 8 |
